Michael K. Gibson

Quick facts

Phase 2 pipeline

• Human Papillomavirus Tumor Antigen Vaccine · Vaccines
  Stimulates an immune response against Human Papillomavirus (HPV) tumor antigens

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Michael K. Gibson portfolio CI brief
• Michael K. Gibson pipeline updates RSS